ADMA - ADMA Bio nabs a U.S. patent for pneumococcal infections April, 17 2019 09:21 AM ADMA Biologics Inc The USPTO has issued ADMA Biologics' (NASDAQ:ADMA) Patent No. 10,259,865 related to methods of treatment and prevention of S. pneumonia infection.More news on: ADMA Biologics, Inc., Healthcare stocks news, Read more ...